In a recent installment of the International Society of Automation’s “Ask the Automation Pros” series, Erik Cornelsen, ...

After losing a third of his bodyweight, Ian Walker, 57, discovered the real challenge wasn’t shedding the pounds – it was ...

Detailed price information for Sasquatch Resources Corp. (SASQ-CN) from The Globe and Mail including charting and trades.

The crypto market's rich vein of volatility extended into Friday morning, with bitcoin BTC $93,751.01 rising from a 1:00 a.m. UTC low of $85,200 to $88,000 over five hours after the Bank of Japan ...

Community organizers say the number of homeless children represented in state testing data is low and does not show the entire picture. In September, preliminary results from the North Carolina ...

Crews are driving test piles into the Patapsco River as part of the Francis Scott Key Bridge replacement project in Baltimore As the last remaining spans of Baltimore’s original Francis Scott Key ...

Officials provided an up-close look at the progress being made at the site of the Key Bridge rebuild on Wednesday. The test pile program involves massive cranes, a gigantic hammer and 12 220-foot ...

THEY HAVE TWO OF THE LARGEST ROTATING CRANES ON THE EAST COAST RIGHT HERE FOR THIS PROJECT AT THE MOMENT. AND THAT’S BECAUSE OF THE SHEER SIZE OF THE PILES THAT THEY’RE DRIVING IN THIS TEST. THE 200FT ...

Officials provided an up-close look at the progress being made at the site of the Key Bridge rebuild on Wednesday. The test pile program involves massive cranes, a gigantic hammer and 12 220-foot ...

A data-center group that is closely linked to Oracle and OpenAI’s Stargate effort could test the market’s willingness to provide the trillions needed to deliver artificial intelligence over the coming ...

The Port of Astoria Commission held a workshop session on Tuesday, focusing on long-term infrastructure needs, equipment purchases and development planning at key facilities, including Piers 1 and 3.

Grail is on a mission to have its cancer blood test become a core part of U.S. screening for a range of tumors. Now, it’s detailing its latest data as it heads to the FDA. Back in June, Grail revealed ...